Sanofi (SNY) Profit After Tax (2009 - 2026)

Sanofi has reported Profit After Tax for 18 years, with the latest figure at $438.2 million in Q2 2026.

• Quarterly Profit After Tax fell 90.18% year-over-year to $438.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.7 billion (down 64.13% YoY) and the FY2025 annual result came in at $9.1 billion, up 52.23% from the prior year.
• Profit After Tax fell to $438.2 million in Q2 2026 per SNY's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Profit After Tax peaked at $10.1 billion in Q3 2025 and troughed at -$7.7 billion in Q4 2025.
• A 5-year average of $2.2 billion and a median of $2.1 billion in 2022 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 271.15% in 2025, down 315.3% in 2025.
• Over 5 years, Profit After Tax stood at $5.4 billion in 2022, then slumped by 60.72% to $2.1 billion in 2023, then jumped by 68.29% to $3.6 billion in 2024, then slumped by 315.3% to -$7.7 billion in 2025, then surged by 105.68% to $438.2 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $438.2 million, $1.9 billion, and -$7.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.